Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study - Wikidata - wikimedia - TriplyDB

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study

http://www.wikidata.org/entity/Q28479309

about

Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis Point-of-care diagnosis of tuberculosis: past, present and future Performance of the WHO 2011 TB Symptom Screening Algorithm for Pulmonary TB Diagnosis among HIV-Infected Patients in Gondar University Referral Hospital, Ethiopia Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation Systematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosis The diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results Community-based active tuberculosis case finding in poor urban settlements of Phnom Penh, Cambodia: a feasible and effective strategy Optimizing tuberculosis case detection through a novel diagnostic device placement model: the case of Uganda Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce The biology of mycobacterium tuberculosis infection.Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda.Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study.Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia Undiagnosed tuberculosis in patients with HIV infection who present with severe anaemia at a district hospital Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes.Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis.Effects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa.Prevalence of national treatment algorithm defined smear positive pulmonary tuberculosis in HIV positive patients in Brazzaville, Republic of Congo Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.High prevalence of tuberculosis and serious bloodstream infections in ambulatory individuals presenting for antiretroviral therapy in Malawi.Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa.Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa.Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study.Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda A diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru.High yield of culture-based diagnosis in a TB-endemic setting.'Cough officer' nurses in a general medical clinic successfully detect drug-susceptible and -resistant tuberculosis.HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays.Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008.Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria.Translating translational research into global health gains.

P2860

Q22241307-11DEA43C-6B6E-48FA-843D-08BB9A0DFFA3 Q24200879-555B0454-82DA-489F-AD4F-E2C5D36ACD1A Q24201466-60D98755-CEE6-4C7C-92F5-0AB2816572FB Q26798435-E017185D-C213-495C-83DC-A83C05F67D31 Q27004667-6A7B4A3C-6BAA-4FC5-B48F-1255D654223F Q28354210-DF29F171-268E-48F3-BF37-237BE0172007 Q28469353-89A1F30C-92B8-482D-A6A9-A8F3E79686BF Q28485280-76840A1F-592B-4E62-96FC-1A415B098083 Q28534025-F8215D1C-9956-43E0-A385-AF3E8DF28738 Q28536945-0A592156-8AD7-4332-AB54-63E71B4B138A Q28540488-DF6BE3CB-534A-447F-AF02-AF92FDBD1662 Q28541624-331BB9F8-282E-45ED-A685-07AE57D1D5A2 Q28545265-291DFEC1-75F7-44DD-88E2-5133C3D7882F Q28547769-5628E460-88AA-478E-9095-1EC0D20BB1AC Q28727351-E0C43ACA-6BFE-43C3-AB7F-896D4FF19C54 Q30357155-E35E12FA-9009-4B22-9730-A0D85BBE5A91 Q31106576-BD339E93-D1FE-4002-AF5B-7619F76EFAC1 Q33742861-B457E5AB-0181-4A4F-A5B1-DEE643C64E06 Q33812641-F796888B-75C7-4F9D-8EDB-C36C70B1A72F Q33896029-3ABE319E-D8B7-44B9-96BD-F8CF2EA27A9F Q33900005-DFA19C5E-7028-4296-8BB6-1408CBD0013E Q33975232-1CEABD92-F1E0-4BCB-A207-AA8E07376A4E Q34076574-9B4E1FFC-DF76-42F4-9E79-A82EB44BF682 Q34203557-CA03C707-AECD-4E63-82DD-79DB784482A1 Q34222186-2BE6F88F-DD6F-41E7-A9C1-A6575AA9E146 Q34326041-E1846E1E-E0D0-48CA-8B20-E6B4F9406F40 Q34340867-94206B2D-4E62-4FEA-848C-4C2E9B76E175 Q34351266-6255C70E-F28F-47DB-AE2E-45407D4C4E01 Q34373838-941724C5-07A7-4CC7-B0A2-986250025F5D Q34384993-09926070-3724-4C2E-89A5-137EEC496DDA Q34391572-88FF3401-3010-44D2-83A6-434CDF3677FA Q34412632-FDE1BC59-9C23-4AE2-B076-8919F459E9CE Q34414709-14AF671E-EB66-4FB1-A2A7-ADA977F75C89 Q34482248-C75BDBEF-4DD2-48AD-AC9F-812CC5B3875C Q34509326-CBFD07F8-C3DC-4B51-A4F3-646FEF68B455 Q34560020-765ACA15-D7F1-4943-ABB4-5A83D288C22A Q34563388-79179205-9017-4A2E-A47C-40D9ECEC8E82 Q34589601-EAF4E171-D32C-4F44-A589-2FC98C88F81D Q34728486-DEA15855-C5F0-41C7-8B57-0FB7E6919082 Q34916434-41005548-FB0A-4AB3-AC2D-D94651F00685

P2860

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study

http://www.wikidata.org/entity/Q28479309

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Screening for HIV-associated t ...... RIF assay: a prospective study

@ast

Screening for HIV-associated t ...... RIF assay: a prospective study

@en

Screening for HIV-associated t ...... RIF assay: a prospective study

@nl

type

label

Screening for HIV-associated t ...... RIF assay: a prospective study

@ast

Screening for HIV-associated t ...... RIF assay: a prospective study

@en

Screening for HIV-associated t ...... RIF assay: a prospective study

@nl

prefLabel

Screening for HIV-associated t ...... RIF assay: a prospective study

@ast

Screening for HIV-associated t ...... RIF assay: a prospective study

@en

Screening for HIV-associated t ...... RIF assay: a prospective study

@nl

P1433

Q28479309-91806B8C-A84B-4C05-8FD9-300B6615A8A2

P1476

Q28479309-E17C04C0-8040-4334-A338-A0502147DFB1

P2093

Q28479309-308993F3-508C-4F87-A61A-53965B59DBCF

Q28479309-55A52EDF-C051-4D27-BBA6-48EACB59ECD0

Q28479309-6DFBA655-A9A6-4B1D-BAE3-94E9A293AEED

P2860

Q28479309-00390BD6-EE49-423A-AEB9-DD0D5C8E30BE

Q28479309-0202C701-49F9-456F-BFC5-DE765021528F

Q28479309-2E53B6B3-6652-4F03-9213-3FC8C2866D45

Q28479309-31ED5C0C-31B5-4DEE-BB89-BB3ADD0685FE

Q28479309-353B0977-5615-4769-BB81-A4D9B9EC2AF9

Q28479309-37A54AFC-EEAF-4185-98C7-7B40B2A603EE

Q28479309-3F740A8A-F93C-4833-B9CB-DC1F34D62204

Q28479309-5908361C-8D14-4502-9B62-71C658B455F5

Q28479309-5C44EC25-69E6-4973-A510-1C1319A6E9A4

Q28479309-5D2F782C-CFAA-42C0-8177-8CAD5C326539

P304

Q28479309-616FCBB4-E28C-476D-ACB4-5F8291A2822A

P31

Q28479309-E3A2B914-44A9-44AD-BBC7-FAE2DD1C5CF4

P3181

Q28479309-3709A33D-A09C-4257-97FC-BB1FA1AACEEC

P356

Q28479309-8DE846EC-0ADF-4501-9006-453DF9E12798

P407

Q28479309-3F53236A-F0A6-4132-BA01-2E12270C8347

P433

Q28479309-EAA1F032-A24E-4BF3-8F66-F623BD8749B1

P478

Q28479309-097D42C6-989A-43AF-BCB4-5A26861E2E06

P50

Q28479309-14FF8C2E-163D-4A96-A577-0AD33A72A216

Q28479309-452ED79D-7D05-4F95-AEB5-50A6ED88F2B2

Q28479309-791B42BA-9CC7-419B-9FE8-2620BBCE9EAF

Q28479309-84B93E73-A458-42D2-BD94-AB7DB3C4FDDE

Q28479309-8D0539C6-3725-41D3-A152-B47605862E90

P577

Q28479309-EC31717C-1F7F-4EAD-9188-6D8C1C736954

P5875

Q28479309-CE4DFF59-BFEC-42EA-AD8F-74D4F15CDCEA

P698

Q28479309-E27B0E18-C727-449A-AE45-98988AA33FB1

P921

Q28479309-0655FEDF-544B-43EA-8D15-E06719E0FC35

Q28479309-CBA1CB88-C039-4359-9E7F-22235C05C060

P932

Q28479309-04CBC940-4B0B-4070-98B8-42872EB5F2F4

P3181

P356

JOURNAL.PMED.1001067

P1433

P1476

Screening for HIV-associated t ...... RIF assay: a prospective study

@en

P2093

Andrew Whitelaw

http://www.w3.org/2001/XMLSchema#string

Monica Vogt

http://www.w3.org/2001/XMLSchema#string

Sophie V Brooks

http://www.w3.org/2001/XMLSchema#string

P2860

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

Rapid molecular detection of tuberculosis and rifampin resistance

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

Evaluation of the analytical performance of the Xpert MTB/RIF assay.

High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers

Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens.

Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system.

Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis

P304

e1001067

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1437527

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.1001067

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Linda-Gail Bekker

Katharina Kranzer

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51548739

http://www.w3.org/2001/XMLSchema#string

P698

21818180

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

antiretroviral drug

P932

3144215

http://www.w3.org/2001/XMLSchema#string